The Corealis leadership team consists of professionals and experts with extensive scientific and service industry experience. Their seasoned careers provide proficient and knowledgeable skills to tackle the most intricate challenges.
David Leroux-Petersen – CEO
Mr. Leroux-Petersen has 20 years of impactful experience in early-stage development, contract manufacturing and therapeutic commercialization.
Mr. Leroux-Petersen earned a Bachelor of Science in Biology from Concordia University and a business degree from the John Molson School of Business. He began his career in the life sciences sector, working at various organizations, including Charles River Laboratories, Algorithm Pharma and the National Research Council of Canada. He rejoined Charles River Laboratories in 2014 and held several leadership roles, including Vice-President Commercial Head Global Discovery and Safety Assessment, Chief Commercial Officer Manufacturing, Vice-President Global Commercial Growth and Vice-President Research Models and Services.
Patrick Gosselin, Ph.D. – Vice-President — Pharmaceutical R&D
Dr. Gosselin handles the drug product formulation and process development of new chemical entities. He also oversees Phase I, II and early Phase III clinical trial material manufacturing. He has a bachelor’s degree in chemical engineering and a doctorate in pharmaceutical technology, both awarded by the Université de Montréal.
Dr. Gosselin has a background in pharma development. He worked for several major companies in a variety of roles, such as R&D project leader for the German company ratiopharm international. While at ratiopharm, he contributed to the development of a range of products and helped establish a center of excellence in R&D.
Dr. Gosselin is an associate professor at the Université du Québec à Montréal. He has published an array of material, including peer-reviewed publications and patents.
Yves Mouget, Ph.D. – Vice-President — Analytics
Dr. Mouget holds a Bachelor of Science degree from Concordia University and a doctorate from the Université de Montréal. On graduating, he joined MDS Sciex as a research and application chemist. There, he developed his understanding of R&D work in the pharmaceutical environment.
In 2000, Dr. Mouget accepted the position of R&D Director at Pharmalaser. His knowledge and experience of the sector deepened, leading to more career progression. In 2003, he joined ratiopharm as Director of Analytical Development. This move placed Yves at the heart of the pharmaceutical development process.
During the course of his career, Dr. Mouget has collaborated with research centers the world over. He has presented and published several respected papers. He appreciates addressing the multifaceted challenges faced by clients in bringing pharmaceutical products to the market.
Contact Corealis
Corealis’ experts are ready to answer any queries about the company’s oral solid dose offering, including its development and manufacturing capabilities.
